Literature DB >> 12956404

Changes in substrate metabolism in isolated mouse hearts following ischemia-reperfusion.

Ellen Aasum1, Anne D Hafstad, Terje S Larsen.   

Abstract

Several genetic and transgenic mouse models are currently being used for studying the regulation of myocardial contractility under normal conditions and in disease states. Little information has been provided, however, about myocardial energy metabolism in mouse hearts. We measured glycolysis, glucose oxidation and palmitate oxidation (using 3H-glucose, 14C-glucose and 3H-palmitate) in isolated working mouse hearts during normoxic conditions (control group) and following a 15 min global no-flow ischemic period (reperfusion group). Fifty min following reperfusion (10 min Langendorff perfusion + 40 min working heart perfusion) aortic flow, coronary flow, cardiac output, peak systolic pressure and heart rate were 44 +/- 4, 88 +/- 4, 57 +/- 4, 94 +/- 2 and 81 +/- 4% of pre-ischemic values). Rates of glycolysis and glucose oxidation in the reperfusion group (13.6 +/- 0.8 and 2.8 +/- 0.2 micromol/min/g dry wt) were not different from the control group (12.3 +/- 0.6 and 2.5 +/- 0.2 micromol/min/g dry wt). Palmitate oxidation, however, was markedly elevated in the reperfusion group as compared to the control group (576 +/- 37 vs. 357 +/- 21 nmol/min/g dry wt, p < 0.05). This change in myocardial substrate utilization was accompanied by a marked fall in cardiac efficiency measured as cardiac output/oxidative ATP production (136 +/- 10 vs. 54 +/- 5 ml/micromol ATP, p < 0.05, control and reperfusion group, respectively). We conclude that ischemia-reperfusion in isolated working mouse hearts is associated with a shift in myocardial substrate utilization in favour of fatty acids, in line with previous observations in rat.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956404

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  25 in total

Review 1.  Physiological assessment of complex cardiac phenotypes in genetically engineered mice.

Authors:  G Christensen; Y Wang; K R Chien
Journal:  Am J Physiol       Date:  1997-06

2.  Inhibition of the phosphofructokinase reaction in perfused rat heart by respiration of ketone bodies, fatty acids and pyruvate.

Authors:  E A NEWSHOLME; P J RANDLE; K L MANCHESTER
Journal:  Nature       Date:  1962-01-20       Impact factor: 49.962

Review 3.  Alterations in fatty acid oxidation during reperfusion of the heart after myocardial ischemia.

Authors:  G D Lopaschuk
Journal:  Am J Cardiol       Date:  1997-08-04       Impact factor: 2.778

4.  Intrinsic A(1) adenosine receptor activation during ischemia or reperfusion improves recovery in mouse hearts.

Authors:  J Peart; J P Headrick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-11       Impact factor: 4.733

5.  The isolated working mouse heart: methodological considerations.

Authors:  T S Larsen; D D Belke; R Sas; W R Giles; D L Severson; G D Lopaschuk; J V Tyberg
Journal:  Pflugers Arch       Date:  1999-05       Impact factor: 3.657

6.  Glucose and fatty acid metabolism in the isolated working mouse heart.

Authors:  D D Belke; T S Larsen; G D Lopaschuk; D L Severson
Journal:  Am J Physiol       Date:  1999-10

7.  Pyruvate reverses fatty-acid-induced depression of ventricular function and calcium overload after hypothermia in guinea pig hearts.

Authors:  E Aasum; T S Larsen
Journal:  Cardiovasc Res       Date:  1997-02       Impact factor: 10.787

8.  Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts.

Authors:  M Saddik; G D Lopaschuk
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

9.  Comparative morphometry of the mitochondria and activity of some enzymes in the myocardium of small mammals.

Authors:  U Oron; M Mandelberg
Journal:  J Mol Cell Cardiol       Date:  1985-06       Impact factor: 5.000

10.  Scaling of oxidative and glycolytic enzymes in mammals.

Authors:  B Emmett; P W Hochachka
Journal:  Respir Physiol       Date:  1981-09
View more
  8 in total

1.  Substrate dependence of the postischemic cardiomyocyte recovery: dissociation between functional, metabolic and injury markers.

Authors:  Cindy Tissier; David Vandroux; Lisa Devillard; Amandine Brochot; Daniel Moreau; Luc Rochette; Pierre Athias
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

2.  PKCε promotes cardiac mitochondrial and metabolic adaptation to chronic hypobaric hypoxia by GSK3β inhibition.

Authors:  Joy McCarthy; Amanda Lochner; Lionel H Opie; Michael N Sack; M Faadiel Essop
Journal:  J Cell Physiol       Date:  2011-09       Impact factor: 6.384

Review 3.  The continuing evolution of the Langendorff and ejecting murine heart: new advances in cardiac phenotyping.

Authors:  Ronglih Liao; Bruno K Podesser; Chee Chew Lim
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

4.  Hepatic mTORC1 Opposes Impaired Insulin Action to Control Mitochondrial Metabolism in Obesity.

Authors:  Blanka Kucejova; Joao Duarte; Santhosh Satapati; Xiaorong Fu; Olga Ilkayeva; Christopher B Newgard; James Brugarolas; Shawn C Burgess
Journal:  Cell Rep       Date:  2016-06-23       Impact factor: 9.423

Review 5.  Loss of Metabolic Flexibility in the Failing Heart.

Authors:  Qutuba G Karwi; Golam M Uddin; Kim L Ho; Gary D Lopaschuk
Journal:  Front Cardiovasc Med       Date:  2018-06-06

6.  The β3 Adrenergic Receptor Antagonist L-748,337 Attenuates Dobutamine-Induced Cardiac Inefficiency While Preserving Inotropy in Anesthetized Pigs.

Authors:  Lars Rødland; Leif Rønning; Anders Benjamin Kildal; Ole-Jakob How
Journal:  J Cardiovasc Pharmacol Ther       Date:  2021-09-23       Impact factor: 2.457

7.  Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity.

Authors:  Darci Phillips; Michiel Ten Hove; Jurgen E Schneider; Colin O Wu; Liam Sebag-Montefiore; Angel M Aponte; Craig A Lygate; Julie Wallis; Kieran Clarke; Hugh Watkins; Robert S Balaban; Stefan Neubauer
Journal:  J Mol Cell Cardiol       Date:  2009-11-11       Impact factor: 5.000

8.  Overexpression of NOX2 Exacerbates AngII-Mediated Cardiac Dysfunction and Metabolic Remodelling.

Authors:  Synne S Hansen; Tina M Pedersen; Julie Marin; Neoma T Boardman; Ajay M Shah; Ellen Aasum; Anne D Hafstad
Journal:  Antioxidants (Basel)       Date:  2022-01-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.